None listed
Conditions
Brief summary
Aim: To determine the most effective way of detecting the incidence of allergic conjunctivitis (AC). Method: The first step includes asking patients in an allergy specialist's outpatient clinic about their Total Ocular Symptom Score (tearing, itching and eye redness), then asking them about indirect symptoms of AC (squinting, blinking, frontal headaches or eyelid dermatitis), and finally using an olopatadine challenge to determine if any chronic, undetected symptoms of AC are relieved and thus suffered. A control group will be used to determine if the lubricating effects of the olopatadine eye drops is acting as the relieving factor in the intervention group.
Interventions
Participants will be asked about their indirect symptoms of AC (squinting, blinking, frontal headaches or eyelid dermatitis) to assess whether they suffer. Then total Ocular Symptom Score (TOSS) (tearing, itching and eye redness) will be assessed.
Then, one drop of olopatadine hydrochloride to each eye, ONCE ONLY.
Then 5 minutes will pass before assessing TOSS again.
Sponsors
A/Prof Peter Smith
Study design
Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Healthy volunteers
Yes
Inclusion criteria
No allergic conjunctivitis Over 18 years Not pregnant CONFIRMED PARTICIPANTS CANT HAVE AR/AC
Exclusion criteria
allergic conjunctivitis/rhinitis
Outcome results
None listed